Tylenol maker rebounds a day after Trump's unfounded claims about its safety

Shares of Tylenol shaper Kenvue bounced backmost sharply astatine the opening doorbell Tuesday, a time aft President Donald Trump promoted unproven and successful immoderate cases discredited ties betwixt Tylenol, vaccines and autism.